Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Stephen Thomas Sonis, D.M.Sc., D.M.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
completed student projects
Effects of Sphingomyelinase Inhibitor on Ionizing Radiation-Induced Apoptosis
Part Time/Continuation, 01/03/01 - 05/31/01
The Role of Endothelial Cell Injury in the Development of Oral Mucositis
Part Time/Continuation, 09/01/00 - 12/31/00
The Rold of Endothelial Cell Injury in the Development of Oral Mucositis
Summer, 06/23/00 - 08/31/00
Treatment of Radiotherapy-Induced Oral Mucositis with In Vivo Blockade of Tumor Necrosis Factor
Part Time/Continuation, 08/01/99 - 06/30/00
Mucositis Research
Summer, 07/01/03 - 08/31/03
Oral Disease and Dental Treatment for Patients Undergoing Cardiac Valve Replacements of Surgical Valve Repair
Part Time, 09/05/01 - 01/31/02
Effects of Sphingomyelinase Inhibitor on Ionizing Radiation-induced Apoptosis
Summer, 06/21/00 - 08/30/00
Development of a Murine Model of Chemotherapy-induced Ulcerative Mucositis and the Treatment of Oral Mucositis with In Vivo Blockade of Tumor Necrosis Factor-X
Part Time/Continuation, 10/01/98 - 06/30/99
Effects of Sphingomyelinase Inhibitor on Ionizing Radiation-Induced Apoptosis
Part Time/Continuation, 09/01/00 - 12/31/00
Therapy-Related Oral and Maxillofacial Complications in Hodgkin’s Lymphoma Survivors: A Sib-Pair Analysis
Summer, 06/15/09 - 08/10/09

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. R13DE013663 (SONIS, STEPHEN T) May 1, 2000 - Apr 30, 2001
    NIH
    MUCOSAL INJURY IN CANCER PATIENTS
    Role: Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Satheeshkumar PS, Blijlevens N, Sonis ST. Application of big data analyses to compare the impact of oral and gastrointestinal mucositis on risks and outcomes of febrile neutropenia and septicemia among patients hospitalized for the treatment of leukemia or multiple myeloma. Support Care Cancer. 2023 Mar 04; 31(3):199. PMID: 36869162.
    Citations:    Fields:    
  2. Lustberg M, Wu X, Fernández-Martínez JL, de Andrés-Galiana EJ, Philips S, Leibowitz J, Schneider B, Sonis S. Leveraging GWAS data derived from a large cooperative group trial to assess the risk of taxane-induced peripheral neuropathy (TIPN) in patients being treated for breast cancer: Part 2-functional implications of a SNP cluster associated with TIPN risk in patients being treated for breast cancer. Support Care Cancer. 2023 Feb 21; 31(3):178. PMID: 36809570.
    Citations:    Fields:    Translation:Humans
  3. Hussein M, Farag YMK, Sonis S. Psoriasis and oral health in adult United States population: a cross-sectional study. BMC Oral Health. 2023 02 02; 23(1):66. PMID: 36732740; PMCID: PMC9896729.
    Citations:    Fields:    Translation:Humans
  4. Lustberg M, Wu X, Fernández-Martínez JL, de Andrés-Galiana EJ, Philips S, Leibowitz J, Schneider B, Sonis S. Identification of a SNP cluster associated with taxane-induced peripheral neuropathy risk in patients being treated for breast cancer using GWAS data derived from a large cooperative group trial. Support Care Cancer. 2023 Jan 28; 31(2):139. PMID: 36707490.
    Citations:    Fields:    Translation:Humans
  5. Sonis S, Saunders D, Villa A. Quantifying Costs Associated With Survival Among Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2023 Jan 19. PMID: 36656592.
    Citations:    Fields:    
  6. Bonomi M, Blakaj DM, Kabarriti R, Colvett K, Takiar V, Biagioli M, Bar-Ad V, Goyal S, Muzyka B, Niermann K, Abrouk N, Oronsky B, Reid T, Caroen S, Sonis S, Sher DJ. PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2023 Jan 14. PMID: 36646388.
    Citations:    Fields:    
  7. Hussein M, Farag YMK, Sonis S. Differential associations of rheumatoid arthritis and periodontitis or tooth loss: A cross-sectional study. J Clin Periodontol. 2023 03; 50(3):307-315. PMID: 36444518.
    Citations:    Fields:    Translation:Humans
  8. van den Hurk CJG, Sonis ST, Epstein JB. A common infrastructure for real-world patient-reported symptoms: one size fits many. Support Care Cancer. 2022 10; 30(10):7833-7834. PMID: 35900594.
    Citations:    Fields:    
  9. Robijns J, Nair RG, Lodewijckx J, Arany P, Barasch A, Bjordal JM, Bossi P, Chilles A, Corby PM, Epstein JB, Elad S, Fekrazad R, Fregnani ER, Genot MT, Ibarra AMC, Hamblin MR, Heiskanen V, Hu K, Klastersky J, Lalla R, Latifian S, Maiya A, Mebis J, Migliorati CA, Milstein DMJ, Murphy B, Raber-Durlacher JE, Roseboom HJ, Sonis S, Treister N, Zadik Y, Bensadoun RJ. Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022. Front Oncol. 2022; 12:927685. PMID: 36110957; PMCID: PMC9468822.
    Citations: 2     
  10. Sonis ST. Precision medicine for risk prediction of oral complications of cancer therapy-The example of oral mucositis in patients receiving radiation therapy for cancers of the head and neck. Front Oral Health. 2022; 3:917860. PMID: 36060117; PMCID: PMC9435998.
    Citations:    
  11. Klein BA, Shazib MA, Villa A, de Abreu Alves F, Vacharotayangul P, Sonis S, Fedele S, Treister NS. Immune checkpoint inhibitors in cancer therapy: Review of orofacial adverse events and role of the oral healthcare provider. Front Oral Health. 2022; 3:968157. PMID: 36060116; PMCID: PMC9427772.
    Citations:    
  12. Anderson CM, Lee CM, Saunders D, Curtis AE, Dunlap NE, Nangia C, Lee AS, Kovoor P, Bar-Ad V, Pedadda AV, Holmlund J, Downs M, Sonis ST. Two-Year Tumor Outcomes of a Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Owing to Concurrent Radiation Therapy and Cisplatin for Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2022 11 01; 114(3):416-421. PMID: 35724774.
    Citations:    Fields:    
  13. Sandhu S, Klein BA, Al-Hadlaq M, Chirravur P, Bajonaid A, Xu Y, Intini R, Hussein M, Vacharotayangul P, Sroussi H, Treister N, Sonis S. Oral lichen planus: comparative efficacy and treatment costs-a systematic review. BMC Oral Health. 2022 05 06; 22(1):161. PMID: 35524296; PMCID: PMC9074269.
    Citations:    Fields:    Translation:Humans
  14. Choi SE, Choudhary A, Huang J, Sonis S, Giuliano AR, Villa A. Increasing HPV vaccination coverage to prevent oropharyngeal cancer: A cost-effectiveness analysis. Tumour Virus Res. 2022 06; 13:200234. PMID: 34974194; PMCID: PMC8749055.
    Citations:    Fields:    Translation:HumansCells
  15. Yaroslavsky AN, Juliano AF, Adnan A, Selting WJ, Iorizzo TW, Carroll JD, Sonis ST, Duncan CN, London WB, Treister NS. Validation of a Monte Carlo Modelling Based Dosimetry of Extraoral Photobiomodulation. Diagnostics (Basel). 2021 Nov 26; 11(12). PMID: 34943447.
    Citations:    
  16. Elad S, Yarom N, Zadik Y, Kuten-Shorrer M, Sonis ST. The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies. CA Cancer J Clin. 2022 01; 72(1):57-77. PMID: 34714553.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  17. Sonis S, Patel J, Ashbury FD. The application of "Omics" to accelerate precision medicine in Supportive Care in Cancer. Support Care Cancer. 2021 Dec; 29(12):7143-7144. PMID: 34546453.
    Citations:    Fields:    Translation:Humans
  18. Klein BA, Alves FA, de Santana Rodrigues Velho J, Vacharotayangul P, Hanna GJ, LeBoeuf NR, Shazib MA, Villa A, Woo SB, Sroussi H, Sonis S, Treister NS. Oral manifestations of immune-related adverse events in cancer patients treated with immune checkpoint inhibitors. Oral Dis. 2022 Jan; 28(1):9-22. PMID: 34265157.
    Citations: 2     Fields:    Translation:Humans
  19. Adnan A, Yaroslavsky AN, Carroll JD, Selting W, Juliano AF, London WB, Sonis ST, Duncan CN, Treister NS. The Path to an Evidence-Based Treatment Protocol for Extraoral Photobiomodulation Therapy for the Prevention of Oral Mucositis. Front Oral Health. 2021; 2:689386. PMID: 35048034; PMCID: PMC8757848.
    Citations:    
  20. Sonis S, Villa A, Epstein J. Exceptional toxicity resistance. Support Care Cancer. 2021 May; 29(5):2263-2264. PMID: 33594509.
    Citations:    Fields:    
  21. Villa A, Vollemans M, De Moraes A, Sonis S. Concordance of the WHO, RTOG, and CTCAE v4.0 grading scales for the evaluation of oral mucositis associated with chemoradiation therapy for the treatment of oral and oropharyngeal cancers. Support Care Cancer. 2021 Oct; 29(10):6061-6068. PMID: 33788003.
    Citations: 1     Fields:    Translation:Humans
  22. Pulsipher A, Savage JR, Kennedy TP, Gupta K, Cuiffo BG, Sonis ST, Lee WY. GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling. PLoS One. 2021; 16(3):e0249343. PMID: 33770116.
    Citations: 2     Fields:    Translation:AnimalsCellsPHPublic Health
  23. Sonis ST. A hypothesis for the pathogenesis of radiation-induced oral mucositis: when biological challenges exceed physiologic protective mechanisms. Implications for pharmacological prevention and treatment. Support Care Cancer. 2021 Sep; 29(9):4939-4947. PMID: 33712912.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  24. Sonis ST. Superoxide Dismutase as an Intervention for Radiation Therapy-Associated Toxicities: Review and Profile of Avasopasem Manganese as a Treatment Option for Radiation-Induced Mucositis. Drug Des Devel Ther. 2021; 15:1021-1029. PMID: 33716500.
    Citations: 2     Fields:    Translation:HumansAnimalsPHPublic Health
  25. Sonis ST. Treatment for Oral Mucositis-Current Options and an Update of Small Molecules Under Development. Curr Treat Options Oncol. 2021 02 17; 22(3):25. PMID: 33595722.
    Citations: 1     Fields:    Translation:Humans
  26. Xu Y, Wen N, Sonis ST, Villa A. Oral side effects of immune checkpoint inhibitor therapy (ICIT): An analysis of 4683 patients receiving ICIT for malignancies at Massachusetts General Hospital, Brigham & Women's Hospital, and the Dana-Farber Cancer Institute, 2011 to 2019. Cancer. 2021 06 01; 127(11):1796-1804. PMID: 33595843.
    Citations: 5     Fields:    Translation:Humans
  27. Choi SE, Choudhary A, Sonis S, Villa A. Benefits of the Involvement of Dentists in Managing Oral Complications Among Patients With Oral Cavity and Oropharyngeal Cancer: An Analysis of Claims Data. JCO Oncol Pract. 2021 11; 17(11):e1668-e1677. PMID: 33555929.
    Citations:    Fields:    Translation:Humans
  28. Sankaran SP, Sonis S. Network meta-analysis from a pairwise meta-analysis design: to assess the comparative effectiveness of oral care interventions in preventing ventilator-associated pneumonia in critically ill patients. Clin Oral Investig. 2021 May; 25(5):2439-2447. PMID: 33537946.
    Citations: 1     Fields:    Translation:Humans
  29. Epstein JB, Dean DR, Sonis ST. Industry and MASCC-an opportunity not to be missed. Support Care Cancer. 2021 Feb; 29(2):559-561. PMID: 33215315.
    Citations:    Fields:    Translation:Humans
  30. Sankaran SP, Villa A, Sonis S. Healthcare-associated infections among patients hospitalized for cancers of the lip, oral cavity and pharynx. Infect Prev Pract. 2021 Mar; 3(1):100115. PMID: 34368735; PMCID: PMC8336044.
    Citations:    
  31. Wardill HR, Sonis ST, Blijlevens NMA, Van Sebille YZA, Ciorba MA, Loeffen EAH, Cheng KKF, Bossi P, Porcello L, Castillo DA, Elad S, Bowen JM. Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action. Support Care Cancer. 2020 Nov; 28(11):5059-5073. PMID: 32592033.
    Citations: 3     Fields:    Translation:Humans
  32. Satheeshkumar PS, Papatheodorou S, Sonis S. Enhanced oral hygiene interventions as a risk mitigation strategy for the prevention of non-ventilator-associated pneumonia: a systematic review and meta-analysis. Br Dent J. 2020 04; 228(8):615-622. PMID: 32332964; PMCID: PMC7223037.
    Citations: 6     Fields:    Translation:Humans
  33. Sonis S. Correction to: Could the impact of photobiomodulation on tumor response to radiation be effected by tumor heterogeneity? Support Care Cancer. 2020 Apr; 28(4):2033. PMID: 32025916.
    Citations:    Fields:    
  34. Cernea A, Fernández-Martínez JL, deAndrés-Galiana EJ, Fernández-Ovies FJ, Alvarez-Machancoses O, Fernández-Muñiz Z, Saligan LN, Sonis ST. Robust pathway sampling in phenotype prediction. Application to triple negative breast cancer. BMC Bioinformatics. 2020 Mar 11; 21(Suppl 2):89. PMID: 32164540.
    Citations: 3     Fields:    Translation:Humans
  35. Villa A, Sonis ST. An update on pharmacotherapies in active development for the management of cancer regimen-associated oral mucositis. Expert Opin Pharmacother. 2020 Apr; 21(5):541-548. PMID: 31990597.
    Citations: 7     Fields:    Translation:Humans
  36. Sonis S. Could the impact of photobiomodulation on tumor response to radiation be effected by tumor heterogeneity? Support Care Cancer. 2020 02; 28(2):423-424. PMID: 31720803.
    Citations: 4     Fields:    
  37. Giralt J, Tao Y, Kortmann RD, Zasadny X, Contreras-Martinez J, Ceruse P, Arias de la Vega F, Lalla RV, Ozsahin EM, Pajkos G, Mazar A, Attali P, Bossi P, Vasseur B, Sonis S, Henke M, Bensadoun RJ. Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2020 02 01; 106(2):320-328. PMID: 31669562.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  38. Anderson CM, Lee CM, Saunders DP, Curtis A, Dunlap N, Nangia C, Lee AS, Gordon SM, Kovoor P, Arevalo-Araujo R, Bar-Ad V, Peddada A, Colvett K, Miller D, Jain AK, Wheeler J, Blakaj D, Bonomi M, Agarwala SS, Garg M, Worden F, Holmlund J, Brill JM, Downs M, Sonis ST, Katz S, Buatti JM. Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer. J Clin Oncol. 2019 12 01; 37(34):3256-3265. PMID: 31618127.
    Citations: 22     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  39. Gupta A, Sonis S, Uppaluri R, Bergmark RW, Villa A. Disparities in Oral Cancer Screening Among Dental Professionals: NHANES 2011-2016. Am J Prev Med. 2019 10; 57(4):447-457. PMID: 31443957.
    Citations: 5     Fields:    Translation:Humans
  40. Lalla RV, Brennan MT, Gordon SM, Sonis ST, Rosenthal DI, Keefe DM. Oral Mucositis Due to High-Dose Chemotherapy and/or Head and Neck Radiation Therapy. J Natl Cancer Inst Monogr. 2019 08 01; 2019(53). PMID: 31425601.
    Citations: 10     Fields:    Translation:Humans
  41. Bowen J, Al-Dasooqi N, Bossi P, Wardill H, Van Sebille Y, Al-Azri A, Bateman E, Correa ME, Raber-Durlacher J, Kandwal A, Mayo B, Nair RG, Stringer A, Ten Bohmer K, Thorpe D, Lalla RV, Sonis S, Cheng K, Elad S. The pathogenesis of mucositis: updated perspectives and emerging targets. Support Care Cancer. 2019 Oct; 27(10):4023-4033. PMID: 31286231.
    Citations: 26     Fields:    Translation:Humans
  42. Ridner SH, Dietrich MS, Sonis ST, Murphy B. Biomarkers Associated with Lymphedema and Fibrosis in Patients with Cancer of the Head and Neck. Lymphat Res Biol. 2018 Nov 28. PMID: 30484735; PMCID: PMC6306661.
    Citations: 2     Fields:    
  43. Bachour PC, Sonis ST. Predicting mucositis risk associated with cytotoxic cancer treatment regimens: rationale, complexity, and challenges. Curr Opin Support Palliat Care. 2018 06; 12(2):198-210. PMID: 29547492.
    Citations: 4     Fields:    Translation:Humans
  44. Villa A, Sonis S. Oral leukoplakia remains a challenging condition. Oral Dis. 2018 Mar; 24(1-2):179-183. PMID: 29480606.
    Citations: 10     Fields:    Translation:Humans
  45. Sonis ST, Villa A. Phase II investigational oral drugs for the treatment of radio/chemotherapy induced oral mucositis. Expert Opin Investig Drugs. 2018 02; 27(2):147-154. PMID: 29323575.
    Citations: 9     Fields:    Translation:HumansAnimalsPHPublic Health
  46. Reinbolt RE, Sonis S, Timmers CD, Fernández-Martínez JL, Cernea A, de Andrés-Galiana EJ, Hashemi S, Miller K, Pilarski R, Lustberg MB. Genomic risk prediction of aromatase inhibitor-related arthralgia in patients with breast cancer using a novel machine-learning algorithm. Cancer Med. 2018 01; 7(1):240-253. PMID: 29168353.
    Citations: 8     Fields:    Translation:Humans
  47. Gupta A, Sonis ST, Schneider EB, Villa A. Impact of the insurance type of head and neck cancer patients on their hospitalization utilization patterns. Cancer. 2018 02 15; 124(4):760-768. PMID: 29112234.
    Citations: 6     Fields:    Translation:Humans
  48. Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, Rabinowits G, Schoenfeld JD, Sonis ST, Thomas T, Tishler RB, Treister NS, Villa A, Woo SB, Haddad R, Mawardi H. The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline. Oncologist. 2017 11; 22(11):1413. PMID: 29123016.
    Citations: 1     Fields:    
  49. Anderson CM, Sonis ST, Lee CM, Adkins D, Allen BG, Sun W, Agarwala SS, Venigalla ML, Chen Y, Zhen W, Mould DR, Holmlund JT, Brill JM, Buatti JM. Phase 1b/2a Trial of the Superoxide Dismutase Mimetic GC4419 to Reduce Chemoradiotherapy-Induced Oral Mucositis in Patients With Oral Cavity or Oropharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2018 02 01; 100(2):427-435. PMID: 29174131; PMCID: PMC6430109.
    Citations: 28     Fields:    Translation:HumansCTClinical Trials
  50. Hashemi S, Fernandez Martinez JL, Saligan L, Sonis S. Exploring Genetic Attributions Underlying Radiotherapy-Induced Fatigue in Prostate Cancer Patients. J Pain Symptom Manage. 2017 09; 54(3):326-339. PMID: 28797855.
    Citations:    Fields:    Translation:Humans
  51. Kuten-Shorrer M, Treister NS, Stock S, Kelley JM, Ji YD, Woo SB, Lerman MA, Palmason S, Sonis ST, Villa A. Topical Clonazepam Solution for the Management of Burning Mouth Syndrome: A Retrospective Study. J Oral Facial Pain Headache. 2017 Summer; 31(3):257-263. PMID: 28738111.
    Citations: 2     Translation:Humans
  52. Sultan AS, Zimering Y, Petruzziello G, Alyea EP, Antin JH, Soiffer RJ, Ho VT, Sonis ST, Woo SB, Marty FM, Treister NS. Oral health status and risk of bacteremia following allogeneic hematopoietic cell transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Sep; 124(3):253-260. PMID: 28823316.
    Citations: 6     Fields:    Translation:Humans
  53. Cinausero M, Aprile G, Ermacora P, Basile D, Vitale MG, Fanotto V, Parisi G, Calvetti L, Sonis ST. New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury. Front Pharmacol. 2017; 8:354. PMID: 28642709; PMCID: PMC5462992.
    Citations: 50     
  54. Kudrimoti M, Curtis A, Azawi S, Worden F, Katz S, Adkins D, Bonomi M, Scott Z, Elder J, Sonis ST, Straube R, Donini O. Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patients. Biotechnol Rep (Amst). 2017 Sep; 15:24-26. PMID: 28649557; PMCID: PMC5470438.
    Citations: 3     
  55. Kuten-Shorrer M, Treister NS, Stock S, Kelley JM, Ji YD, Woo SB, Lerman MA, Palmason S, Sonis ST, Villa A. Safety and tolerability of topical clonazepam solution for management of oral dysesthesia. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Aug; 124(2):146-151. PMID: 28606830.
    Citations:    Fields:    Translation:Humans
  56. Sonis ST. The Chicken or the Egg? Changes in Oral Microbiota as Cause or Consequence of Mucositis During Radiation Therapy. EBioMedicine. 2017 Apr; 18:7-8. PMID: 28330600.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  57. Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, Rabinowits G, Schoenfeld JD, Sonis ST, Thomas T, Tishler RB, Treister NS, Villa A, Woo SB, Haddad R, Mawardi H. The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline. Oncologist. 2017 03; 22(3):343-350. PMID: 28209748.
    Citations: 14     Fields:    Translation:Humans
  58. Kim DW, Garon EB, Jatoi A, Keefe DM, Lacouture ME, Sonis S, Gernhardt D, Wang T, Giri N, Doherty JP, Nadanaciva S, O'Connell J, Sbar E, Cho BC. Impact of a planned dose interruption of dacomitinib in the treatment of advanced non-small-cell lung cancer (ARCHER 1042). Lung Cancer. 2017 04; 106:76-82. PMID: 28285698.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  59. Sonis S, Andreotta PW, Lyng G. On the pathogenesis of mTOR inhibitor-associated stomatitis (mIAS)-studies using an organotypic model of the oral mucosa. Oral Dis. 2017 Apr; 23(3):347-352. PMID: 27896917.
    Citations: 8     Fields:    Translation:Humans
  60. Fernández-Martínez JL, deAndrés-Galiana EJ, Sonis ST. Genomic data integration in chronic lymphocytic leukemia. J Gene Med. 2017 Jan; 19(1-2). PMID: 27928896.
    Citations: 5     Fields:    Translation:HumansCells
  61. deAndrés-Galiana EJ, Fernández-Martínez JL, Sonis ST. Sensitivity analysis of gene ranking methods in phenotype prediction. J Biomed Inform. 2016 12; 64:255-264. PMID: 27793724.
    Citations: 7     Fields:    Translation:Humans
  62. Kudrimoti M, Curtis A, Azawi S, Worden F, Katz S, Adkins D, Bonomi M, Elder J, Sonis ST, Straube R, Donini O. Dusquetide: A novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomized, placebo-controlled phase 2a clinical study. J Biotechnol. 2016 Dec 10; 239:115-125. PMID: 27746305.
    Citations: 16     Fields:    Translation:HumansAnimalsCTClinical Trials
  63. Deandrés-Galiana EJ, Fernández-Martínez JL, Saligan LN, Sonis ST. Impact of Microarray Preprocessing Techniques in Unraveling Biological Pathways. J Comput Biol. 2016 Dec; 23(12):957-968. PMID: 27494192; PMCID: PMC6445216.
    Citations: 4     Fields:    Translation:HumansCells
  64. Villa A, Sonis ST. Pharmacotherapy for the management of cancer regimen-related oral mucositis. Expert Opin Pharmacother. 2016 Sep; 17(13):1801-7. PMID: 27477002.
    Citations: 18     Fields:    Translation:HumansAnimals
  65. Wardill HR, Mander KA, Van Sebille YZ, Gibson RJ, Logan RM, Bowen JM, Sonis ST. Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction. Int J Cancer. 2016 Dec 15; 139(12):2635-2645. PMID: 27367824.
    Citations: 35     Fields:    Translation:HumansAnimalsCells
  66. Sonis ST. Ultrasound-mediated drug delivery. Oral Dis. 2017 Mar; 23(2):135-138. PMID: 27171556.
    Citations: 1     Fields:    Translation:Humans
  67. deAndrés-Galiana EJ, Fernández-Martínez JL, Sonis ST. Design of Biomedical Robots for Phenotype Prediction Problems. J Comput Biol. 2016 08; 23(8):678-92. PMID: 27347715; PMCID: PMC4986153.
    Citations: 7     Fields:    Translation:Humans
  68. Villa A, Sonis S. Toxicities associated with head and neck cancer treatment and oncology-related clinical trials. Curr Probl Cancer. 2016 Sep - Dec; 40(5-6):244-257. PMID: 27520848.
    Citations: 2     Fields:    Translation:Humans
  69. Lacouture ME, Keefe DM, Sonis S, Jatoi A, Gernhardt D, Wang T, Doherty JP, Giri N, Nadanaciva S, O'Connell J, Sbar E, Piperdi B, Garon EB. A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer. Ann Oncol. 2016 09; 27(9):1712-8. PMID: 27287210; PMCID: PMC6279098.
    Citations: 21     Fields:    Translation:HumansCTClinical Trials
  70. Vasconcelos RM, Sanfilippo N, Paster BJ, Kerr AR, Li Y, Ramalho L, Queiroz EL, Smith B, Sonis ST, Corby PM. Host-Microbiome Cross-talk in Oral Mucositis. J Dent Res. 2016 07; 95(7):725-33. PMID: 27053118; PMCID: PMC4914867.
    Citations: 35     Fields:    Translation:Humans
  71. Chen P, Mancini M, Sonis ST, Fernandez-Martinez J, Liu J, Cohen EE, Toback FG. A Novel Peptide for Simultaneously Enhanced Treatment of Head and Neck Cancer and Mitigation of Oral Mucositis. PLoS One. 2016; 11(4):e0152995. PMID: 27049860.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  72. Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Sonis ST, Elad S, Hamblin MR, Barasch A, Migliorati CA, Milstein DM, Genot MT, Lansaat L, van der Brink R, Arnabat-Dominguez J, van der Molen L, Jacobi I, van Diessen J, de Lange J, Smeele LE, Schubert MM, Bensadoun RJ. Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations. Support Care Cancer. 2016 06; 24(6):2781-92. PMID: 26984240.
    Citations: 56     Fields:    Translation:Humans
  73. Sonis ST, Amaral Mendes R. Could the PI3K canonical pathway be a common link between chronic inflammatory conditions and oral carcinogenesis? J Oral Pathol Med. 2016 Aug; 45(7):469-74. PMID: 26991523.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  74. Sonis ST, Hashemi S, Epstein JB, Nair RG, Raber-Durlacher JE. Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients. Oral Oncol. 2016 Mar; 54:7-14. PMID: 26852286.
    Citations: 38     Fields:    Translation:HumansCellsPHPublic Health
  75. Aprile G, Rihawi K, De Carlo E, Sonis ST. Treatment-related gastrointestinal toxicities and advanced colorectal or pancreatic cancer: A critical update. World J Gastroenterol. 2015 Nov 07; 21(41):11793-803. PMID: 26557003; PMCID: PMC4631977.
    Citations: 9     Fields:    Translation:HumansAnimals
  76. Lau A, Dodson TB, Sonis ST, Kaban LB. An Outcomes Study of 40 Years of Graduates of a General Practice Dental Residency. J Dent Educ. 2015 Aug; 79(8):888-96. PMID: 26246526.
    Citations:    Fields:    Translation:Humans
  77. Villa A, Sonis ST. Mucositis: pathobiology and management. Curr Opin Oncol. 2015 May; 27(3):159-64. PMID: 25774860.
    Citations: 79     Fields:    Translation:Humans
  78. Mawardi HH, Elbadawi LS, Sonis ST. Current understanding of the relationship between periodontal and systemic diseases. Saudi Med J. 2015 Feb; 36(2):150-8. PMID: 25719577; PMCID: PMC4375690.
    Citations: 10     Fields:    Translation:Humans
  79. Villa A, Stock S, Aboalela A, Lerman MA, Woo SB, Sonis ST, Treister NS. Oral Medicine referrals at a hospital-based practice in the United States. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Apr; 119(4):423-9. PMID: 25758844.
    Citations: 4     Fields:    Translation:Humans
  80. Sonis ST. Genomics, personalized medicine, and supportive cancer care. Am Soc Clin Oncol Educ Book. 2015; 9-16. PMID: 25993135.
    Citations: 2     Fields:    Translation:Humans
  81. Villa A, Aboalela A, Luskin KA, Cutler CS, Sonis ST, Woo SB, Peterson DE, Treister NS. Mammalian target of rapamycin inhibitor-associated stomatitis in hematopoietic stem cell transplantation patients receiving sirolimus prophylaxis for graft-versus-host disease. Biol Blood Marrow Transplant. 2015 Mar; 21(3):503-8. PMID: 25482865.
    Citations: 4     Fields:    Translation:HumansCells
  82. Wardill HR, Van Sebille YZ, Mander KA, Gibson RJ, Logan RM, Bowen JM, Sonis ST. Toll-like receptor 4 signaling: a common biological mechanism of regimen-related toxicities: an emerging hypothesis for neuropathy and gastrointestinal toxicity. Cancer Treat Rev. 2015 Feb; 41(2):122-8. PMID: 25512119.
    Citations: 11     Fields:    Translation:HumansCells
  83. Saligan LN, Fernández-Martínez JL, deAndrés-Galiana EJ, Sonis S. Supervised classification by filter methods and recursive feature elimination predicts risk of radiotherapy-related fatigue in patients with prostate cancer. Cancer Inform. 2014; 13:141-52. PMID: 25506196; PMCID: PMC4251540.
    Citations: 16     
  84. Lalla RV, Choquette LE, Curley KF, Dowsett RJ, Feinn RS, Hegde UP, Pilbeam CC, Salner AL, Sonis ST, Peterson DE. Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer. Oral Oncol. 2014 Nov; 50(11):1098-103. PMID: 25151488.
    Citations: 9     Fields:    Translation:Humans
  85. Sonis S, Elting L, Keefe D, Nguyen H, Grunberg S, Randolph-Jackson P, Brennan M. Unanticipated frequency and consequences of regimen-related diarrhea in patients being treated with radiation or chemoradiation regimens for cancers of the head and neck or lung. Support Care Cancer. 2015 Feb; 23(2):433-9. PMID: 25123194.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  86. Yuan A, Sonis S. Emerging therapies for the prevention and treatment of oral mucositis. Expert Opin Emerg Drugs. 2014 Sep; 19(3):343-51. PMID: 25102771.
    Citations: 9